Asia-pacific Neuroprosthetics market size was around USD 1.28 Billion in 2017.It is expected to grow at a CAGR of 14.92% to reach 2.56 Billion by 2022.
Neural prosthetics are a class of gadgets that can substitute an engine, tangible or cognitive modality that might be affected due to an injury or an ailment. Cochlear implants are an illustration of such devices. These devices substitute the tasks performed by the ear drum and stapes while simulating the frequency analysis performed in the cochlea. The major purpose of neuroprosthetics is the recovery of a patient's engine capacities through the reclamation of the ones that are harmed.
Some of the key factors driving this market are rising elderly population, lower cost in comparison to conventional treatment methods, increasing cases of Epilepsy, and increasing awareness towards neural prosthetics.
With respect to type, the market is segmented into Motor Prosthetics, Auditory Prosthetics, Cognitive Prosthetics, and Visual Prosthetics. With respect to technology, the market is divided into Deep Brain Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, and Sacral Nerve Stimulation. By application, the market is categorised into Motor Neuron Disorders, Physiological disorders, and Cognitive Disorders. By end user, the market is divided into hospitals and clinics.
By geography, the market is segmented into India, China, Korea, Japan and others. Asia Pacific is anticipated to be the fastest growing segment due to the introduction of multinational healthcare establishments promoting safe and effective medical procedures along with the rising awareness levels amongst consumers.
Some of the major manufacturers of neuroprosthetics include Cochlear Ltd., Boston Scientific Corporation, Cyberonics Inc., Medtronic plc, NDI Medical LLC, NeuroPace Inc., St. Jude Medical Inc., Nervo Corp., Retina Implant AG, Biomet Inc., and Sonova.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Motor Prosthetic
5.1.3 Auditory Prosthetics
5.1.4 Visual Prosthetics
5.1.5 Cognitive Prosthetics
5.1.6 Y-o-Y Growth Analysis, By Type
5.1.7 Market Attractiveness Analysis, By Type
5.1.8 Market Share Analysis, By Type
5.2 Technology
5.2.1 Introduction
5.2.2 Deep Brain Stimulation
5.2.3 Vagus Nerve Stimulation
5.2.5 Spinal Cord Stimulation
5.2.6 Y-o-Y Growth Analysis, By Technology
5.2.7 Market Attractiveness Analysis, By Technology
5.2.8 Market Share Analysis, By Technology
5.3 Application
5.3.1 Introduction
5.3.2 Motor Neuron Disorders
5.3.3 Physiological disorders
5.3.4 Cognitive disorders
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
5.4 End-user
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Clinics
5.4.7 Y-o-Y Growth Analysis, By End-user
5.4.8 Market Attractiveness Analysis, By End-user
5.4.9 Market Share Analysis, By End-user
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Technology
6.1.3.4 By Application
6.1.3.5 By End-user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Technology
6.1.4.4 By Application
6.1.4.5 By End-user
6.1.5 Market Share Analysis
6.1.5.2 By Type
6.1.5.3 By Technolgy
6.1.5.4 By Application
6.1.5.5 By End-user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Cochlear Ltd
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Cochlear Ltd
8.3 Boston Scientific Corporation
8.4 Cyberonics Inc
8.5 Medtronic plc
8.6 NDI Medical LLC
8.7 NeuroPace Inc
8.8 St. Jude Medical Inc.
8.9 Nervo Corp
8.10 Retina Implant AG
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
